Shares of Zoetis have been roughly average performers over the past decade. The shares seem appealingly valued at recent ...

Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.850 billion of senior notes, consisting of $850.0 ...

The reality is that people and animals will always need medicine, treatments, and other products to live long and comfortable ...

Q2 2025 Management View Kristin C. Peck, CEO, reported "strong broad-based 8% organic operational revenue growth" and noted ...

Zoetis (NYSE:ZTS) added ~7% in the premarket on Tuesday after the animal health company exceeded Street forecasts with its Q2 ...

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the ...

Q2 2025 Earnings Conference Call August 5, 2025 8:30 AM ET. Company Participants. Kristin C. Peck - CEO & Director Steven Frank - Vice President of Investor ...

NYSE:ZTS 1 Year Share Price vs Fair Value Explore Zoetis's Fair Values from the Community and select yours Zoetis ...

Zoetis Inc. Q2 2025 earnings highlight 8% organic revenue growth, raised guidance, and strong performance from Simparica and Key Dermatology franchises.

Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and vaccines for pets, sending the animal healthcare company's shares surging ...

The global Veterinary Diagnostics Market, valued at US$3.42 billion in 2024 stood at US$3.68 billion in 2025 and is projected ...